Signalling in osteoclasts and the role of Fos/AP1 proteins.
Wagner
E F
EF
IMP, Research Institute of Molecular Pathology, Dr. Bohr-Gasse 7, A-1030 Vienna, Austria. wagner@imp.univie.ac.at
Matsuo
K
K
D000818:Animals; D001846:Bone Development / Q000502:physiology; D006023:Glycoproteins / Q000502:physiology; D006801:Humans; D051379:Mice; D010010:Osteoclasts / Q000502:physiology*; D053244:Osteoprotegerin; D016760:Proto-Oncogene Proteins c-fos / Q000502:physiology*; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor; D015398:Signal Transduction / Q000502:physiology*; D018808:Transcription Factor AP-1 / Q000502:physiology*
D006023:Glycoproteins; D053244:Osteoprotegerin; D016760:Proto-Oncogene Proteins c-fos; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human; C506031:Tnfrsf11b protein, mouse; D018808:Transcription Factor AP-1